By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...